Customized diagnostic platforms for liquid biopsy and cell dispensing will be used in the future for an increasing number of automated and modular analyses to enable more efficient and targeted individual therapies for diseases such as tumors.

The use of rapid nucleic acid analysis for the detection of circulating nucleic acids can also provide information about a patient's condition. To ensure fast analysis, the combination of automation and rapid test platforms for nucleic acid and a wide range of applications is offered. In particular, the use of microfluidic systems enables low-cost on-demand testing with minimal sample preparation and fast, precise analysis.

The precise deposition of human cells, including patient cells for use in pharmaceutical development and therapy discovery, as well as in the field of tissue engineering, is also covered by our microfluidic developments on display this year. The technology in the field of 3D bioprinting is characterized by high printing speed, high viability of the printed cells and high resolution due to the dispensing of microdroplets smaller than 20pL.

Interested in our technologies? Make an appointment and get in touch with our applied research experts.

Visit us in Hall 3 Booth E74 at the Fraunhofer joint booth.

Our exhibits

CTCelect - Single cell isolation of rare cells

Here we present our expertise and a system for the automated enrichment and isolation of rare cells (e.g. circulating tumor cells) liquid biopsies or dissociated tissue. One Highlight is our VR game to our system for the automated isolation of rare cells.

PCR on single cells

We develop microfluidic amplification technologies for detection, quantification & analysis of nucleic acids. At Medica 2024, we will present a microfluidic amplification system that can perform sensitive PCR on single cells and isothermal amplifications of free circulating (cf)DNA.

On-demand single cell dispensing, 3D-bioprinting

We present a microfluidic technology for automated on-demand dispensing of cell bio-printing. Our development enables the dispensing of cells encapsulated in the smallest possible volume, for example to avoid dilution during drug testing or to place cell next to cell with the highest precision during bio-printing so that they can immediately form cell-cell contacts.

We are developing a microfluidic silicon chip based on inkjet printing technology that can deposit individual human cells in a targeted manner. Fields of application include the very fast dispensing of cell culture cells, the generation of spheroids and organoids.

The driving vision is the additive manufacturing of tissues by ejecting cells that can be deposited in a volume of less than 20 picoliters, enveloped in tiny microdroplets.

Keywords for talking to our experts on site:

  • automated rapid test systems,
  • microfluidics-based diagnostics
  • Point-of-care testing
  • automation of diagnostics
  • Lab-on-chip systems
  • personalized diagnostics
  • single cell dispensing
  • 3D-bioprinting

Our presentions

Microfluidics meets Liquid Biopsy & Single Cell Technologies: Applications & Network Activities

Who? Dr. Christian Freese | Fraunhofer IMM_
When? November 12, 2024 | 2:55 p.m. – 3:10 p.m.
Where? MEDICA LABMED FORUM 2024 | Hall 1 Booth G37
To the presentation on the trade fair page

 

Wearables - adding a new dimension to laboratory medicine

Who? Dr. Taleieh Rajabi | Fraunhofer IMM
When? November 13, 2024 | 11:00 a.m. – 11:20 a.m.
Where? MEDICA LABMED FORUM 2024 | Hall 1 Booth G37
Information on the trade fair website will follow

Further information